Cargando…
Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale
Many factors influence the choice of methods used to develop antibody to infectious agents. In this paper, we review the current status of the main technologies used to produce monoclonal antibodies (mAbs) from the B cells of antigen-sensitized animals. While companies are adopting advanced high-thr...
Autor principal: | Berry, Jody D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110446/ https://www.ncbi.nlm.nih.gov/pubmed/16129340 http://dx.doi.org/10.1016/j.tvjl.2004.04.021 |
Ejemplares similares
-
Viral Biothreat Agents
por: Anderson, Kevin
Publicado: (2009) -
Biothreat Agents and Emerging Infectious Disease in the Emergency Department
por: Adalja, Amesh A.
Publicado: (2018) -
Pathogenic Bacilli as an Emerging Biothreat?
por: Mondange, Lou, et al.
Publicado: (2022) -
Advances in Development of Countermeasures for Potential Biothreat Agents
por: Pittman, Phillip R., et al.
Publicado: (2012) -
Advances in Molecular Diagnostic Approaches for Biothreat Agents
por: Rastogi, Meghana, et al.
Publicado: (2019)